Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artivion, Inc. stock logo
AORT
Artivion
$30.70
+0.7%
$29.88
$21.97
$32.94
$1.31B1.62338,215 shs64,536 shs
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$1.91
+1.9%
$2.17
$0.90
$4.98
$471.09M2.463.25 million shs1.01 million shs
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$32.51
-0.4%
$33.46
$27.07
$40.28
$1.32B1.31254,728 shs34,396 shs
CONMED Corporation stock logo
CNMD
CONMED
$48.06
+0.9%
$54.77
$46.00
$78.19
$1.49B1.2445,585 shs82,188 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artivion, Inc. stock logo
AORT
Artivion
0.00%-3.21%+0.53%+34.78%+11.90%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
0.00%+3.31%-9.88%-17.62%+74.77%
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.00%-0.37%-0.75%+11.97%-13.30%
CONMED Corporation stock logo
CNMD
CONMED
0.00%-7.00%-8.77%-0.19%-32.89%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Artivion, Inc. stock logo
AORT
Artivion
2.0647 of 5 stars
1.65.00.00.00.62.51.9
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
2.6123 of 5 stars
3.51.00.00.03.02.50.6
Cadre Holdings, Inc. stock logo
CDRE
Cadre
3.3159 of 5 stars
2.31.02.50.03.63.31.9
CONMED Corporation stock logo
CNMD
CONMED
4.7932 of 5 stars
3.12.02.54.32.60.83.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Artivion, Inc. stock logo
AORT
Artivion
3.17
Buy$32.405.55% Upside
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
3.00
Buy$3.5083.73% Upside
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.50
Moderate Buy$37.5015.37% Upside
CONMED Corporation stock logo
CNMD
CONMED
2.20
Hold$62.2029.42% Upside

Current Analyst Ratings Breakdown

Latest BFLY, CNMD, CDRE, and AORT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/1/2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$3.00
6/17/2025
Artivion, Inc. stock logo
AORT
Artivion
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$35.00
6/13/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$45.00 ➝ $38.00
6/12/2025
CONMED Corporation stock logo
CNMD
CONMED
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$61.00
5/6/2025
Artivion, Inc. stock logo
AORT
Artivion
Citizens Jmp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/6/2025
Artivion, Inc. stock logo
AORT
Artivion
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$33.00 ➝ $33.00
5/6/2025
Artivion, Inc. stock logo
AORT
Artivion
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$32.00 ➝ $32.00
5/5/2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$5.00 ➝ $4.00
5/1/2025
CONMED Corporation stock logo
CNMD
CONMED
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$70.00 ➝ $58.00
5/1/2025
CONMED Corporation stock logo
CNMD
CONMED
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$70.00 ➝ $57.00
5/1/2025
CONMED Corporation stock logo
CNMD
CONMED
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$91.00 ➝ $61.00
(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Artivion, Inc. stock logo
AORT
Artivion
$388.54M3.37$0.84 per share36.55$6.59 per share4.66
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$82.06M5.74N/AN/A$0.79 per share2.41
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$567.56M2.33$1.41 per share23.04$7.67 per share4.24
CONMED Corporation stock logo
CNMD
CONMED
$1.31B1.14$6.78 per share7.09$31.16 per share1.54
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Artivion, Inc. stock logo
AORT
Artivion
-$13.36M-$0.50N/A61.39N/A-5.49%3.63%1.34%8/6/2025 (Estimated)
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$72.49M-$0.29N/AN/AN/A-75.56%-29.97%-21.13%8/1/2025 (Confirmed)
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$36.13M$0.9534.2323.901.206.87%12.52%6.04%8/8/2025 (Estimated)
CONMED Corporation stock logo
CNMD
CONMED
$132.42M$3.8012.669.481.239.02%14.36%5.86%7/30/2025 (Estimated)

Latest BFLY, CNMD, CDRE, and AORT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Artivion, Inc. stock logo
AORT
Artivion
$0.11N/AN/AN/AN/AN/A
8/8/2025Q2 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.25N/AN/AN/A$153.23 millionN/A
8/1/2025Q2 2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$0.07N/AN/AN/A$23.91 millionN/A
7/30/2025Q2 2025
CONMED Corporation stock logo
CNMD
CONMED
$1.13N/AN/AN/A$338.42 millionN/A
5/6/2025Q1 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.13$0.23+$0.10$0.23$121.53 million$130.11 million
5/5/2025Q1 2025
Artivion, Inc. stock logo
AORT
Artivion
$0.12$0.06-$0.06-$0.01$94.81 million$98.98 million
5/2/2025Q1 2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$0.09-$0.06+$0.03-$0.06$21.16 million$21.23 million
4/30/2025Q1 2025
CONMED Corporation stock logo
CNMD
CONMED
$0.81$0.95+$0.14$0.19$313.38 million$321.26 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Artivion, Inc. stock logo
AORT
Artivion
N/AN/AN/AN/AN/A
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/AN/AN/AN/AN/A
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.381.17%N/A40.00%2 Years
CONMED Corporation stock logo
CNMD
CONMED
$0.801.66%N/A21.05%N/A

Latest BFLY, CNMD, CDRE, and AORT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/21/2025
CONMED Corporation stock logo
CNMD
CONMED
quarterly$0.201.34%6/13/20256/13/20257/3/2025
4/22/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.09501.29%5/2/20255/2/20255/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Artivion, Inc. stock logo
AORT
Artivion
1.08
5.53
3.95
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/A
6.06
4.43
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.66
3.55
2.57
CONMED Corporation stock logo
CNMD
CONMED
0.91
2.26
1.00

Institutional Ownership

CompanyInstitutional Ownership
Artivion, Inc. stock logo
AORT
Artivion
86.37%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
37.85%
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
CONMED Corporation stock logo
CNMD
CONMED
N/A

Insider Ownership

CompanyInsider Ownership
Artivion, Inc. stock logo
AORT
Artivion
8.10%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
25.18%
Cadre Holdings, Inc. stock logo
CDRE
Cadre
37.00%
CONMED Corporation stock logo
CNMD
CONMED
3.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Artivion, Inc. stock logo
AORT
Artivion
1,60042.70 million39.24 millionOptionable
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
460247.29 million185.02 millionOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,28440.66 million25.62 millionOptionable
CONMED Corporation stock logo
CNMD
CONMED
3,90030.94 million29.98 millionOptionable

Recent News About These Companies

Head to Head Review: CONMED (NYSE:CNMD) & Lifevantage (NASDAQ:LFVN)
Brokerages Set CONMED Corporation (NYSE:CNMD) PT at $62.20
Conmed Board Member Martha Aronson Resigns

New MarketBeat Followers Over Time

Media Sentiment Over Time

Artivion stock logo

Artivion NYSE:AORT

$30.70 +0.21 (+0.67%)
As of 11:51 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Butterfly Network stock logo

Butterfly Network NYSE:BFLY

$1.90 +0.04 (+1.87%)
As of 11:51 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Cadre stock logo

Cadre NYSE:CDRE

$32.51 -0.14 (-0.41%)
As of 11:51 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

CONMED stock logo

CONMED NYSE:CNMD

$48.06 +0.42 (+0.89%)
As of 11:52 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.